you are here:

Thyrocare Technologies Ltd.

BSE: 539871 | NSE: THYROCARE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE594H01019 | SECTOR: Hospitals & Medical Services

BSE Live

Nov 27, 16:00
1095.00 43.75 (4.16%)
Volume
AVERAGE VOLUME
5-Day
21,919
10-Day
18,474
30-Day
20,877
27,915
  • Prev. Close

    1051.25

  • Open Price

    1030.05

  • Bid Price (Qty.)

    1090.00 (10)

  • Offer Price (Qty.)

    1095.00 (38)

NSE Live

Nov 27, 15:58
1098.25 50.60 (4.83%)
Volume
AVERAGE VOLUME
5-Day
282,930
10-Day
202,379
30-Day
279,661
453,363
  • Prev. Close

    1047.65

  • Open Price

    1048.00

  • Bid Price (Qty.)

    1098.25 (2676)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Thyrocare Techn

  • Nov 27, 2020 19:24 Source: BSE

    Thyrocare Technologies - Disclosure Of Related Party Transactions Pursuant To Regulation 23 (9) Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

    Pursuant to Regulation 23 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are filing herewith Disclosure of Related Party Transactions during the half year ended on September 30, 2020 on a consolidated basis, in the format specified in the accounting standards, and the same is also available on the website of the Company viz, www.thyrocare.com. Please take the same on record.

  • Nov 23, 2020 13:36 Source: BSE

    Thyrocare Technologies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the representatives of Wellington Management Hong Kong Ltd. would be having a Con-call with us, at 11.30 A.M. on Tuesday, November 24, 2020. Please note that this is subject to any last minute changes.

  • Nov 10, 2020 13:15 Source: BSE

    Thyrocare Technologies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the representatives of Arisaig Partners would be having a Con-call (Zoom Meeting) with us, at 5.00 P.M. today, i.e. Tuesday, November 10, 2020. Please note that this is subject to any last minute changes.

  • Nov 06, 2020 17:26 Source: BSE

    Thyrocare Technologies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith the transcript of the Earnings Call held on Tuesday, November 03, 2020 at 12.00 Noon local time, post declaration of the Company''s unaudited financial results (Stand-alone and Consolidated) for Quarter / Half Year ended September 30, 2020. This transcript is also made available at our website. Dr. A. Velumani, Chairman & Managing Director, Mr. Arindam Haldar, CEO, Mr. A. Sundararaju, CFO & Executive Director, Mr. Sachin Salvi, Vice-President- Finance, represented the Company.

  • Nov 02, 2020 14:36 Source: BSE

    Thyrocare Technologies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a conference call for the Indian and overseas analysts is arranged by our management to discuss the Company''s financial results for Quarter / Six Months ended September 30, 2020, on Tuesday, November 03, 2020 at 12.00 Noon local time. Dr. A. Velumani, Chairman & Managing Director, Mr. Arindam Haldar, Chief Executive Officer, Mr. A. Sundararaju, CFO & Executive Director and Mr. Sachin Salvi, Vice-President- Finance, will represent the Company. Dial-in details are given in the copy of enclosed Invite of M/s. Nomura Financial Advisory & Securities (India) Pvt. Ltd., who is organizing the con-call.

  • Oct 29, 2020 20:52 Source: BSE

    Thyrocare Technologies - Corporate Action- Record Date For The Purpose Of Dividend Is November 13, 2020

    Please refer to our letter dated 28-10-2020 communicating the outcome of the Board Meeting held yesterday, wherein we had intimated to you that the Board of Directors of the Company have declared an Interim Dividend of Rs. 10/- (Rupees Ten only) Per Share for the Financial Year 2020-21. Please note that Friday, 13th November 2020, has been fixed as the record date for the purpose of determining the eligibility of shareholders for the interim dividend as above.

  • Oct 29, 2020 8:56 Source: BSE

    Thyrocare Technologies - Board declares Interim Dividend

    Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 28, 2020, inter alia, have approved payment of interim dividend for the financial year 2020-21, at the rate of Rs. 10/- (Rupees Ten only) per share (100% of the face value of Rs. 10/­ each).

  • Oct 28, 2020 21:51 Source: BSE

    Thyrocare Technologies - Announcement under Regulation 30 (LODR)-Investor Presentation

    We are forwarding a copy of Presentation on Quarterly Results of our company for the quarter / half year ended 30-09-2020. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised.

  • Oct 28, 2020 21:37 Source: BSE

    Thyrocare Technologies - Results- Financial Results For The Period Ended 30-09-2020

    This is inform that the BOD, at their meeting held today, approved unaudited FR (Stand-alone and Consolidated) for the Quarter / Half year ended 30-09-2020 and also approved payment of interim dividend for the FY 2020-21, at the rate of Rs. 10/- The Stand-alone and Consolidated unaudited FR for the quarter / half year ended 30-09-2020, along with the Limited Review Reports, are attached pursuant to Regulation 33 (3) (a) to (c) of SEBI (LODR) Regulations, 2015. We declare that Statutory auditors have issued unmodified opinion on both the Stand-alone and Consolidated Financial Results. The BOD took on record the recent changes in the KMP: 1. Dr. A. Velumani, Chairman, who was reappointed at the 20th AGM held on 29-09-2020 would be the MD. 2. Mr. A. Sundararaju, who was reappointed at the 20th AGM held on 29-09-2020 would be the Executive Director & CFO. 3. Mr. Arindam Haldar would be the CEO. Meeting commenced at 17.00 hours and ended at 21.10 hours today, the 28-10-2020

  • Oct 28, 2020 21:32 Source: BSE

    Thyrocare Technologies - Outcome Of Board Meeting Held On 28-10-2020

    Outcome of Board Meeting held on 28-10-2020

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Oct 28, 2020
Remark : Quarterly Results & Interim Dividend